HD-OPM Archive
Topics › Fasting & meal timing

5:2 fasting beat metformin and empagliflozin for weight and HbA1c in new type 2 diabetes

Louis Nervegna · Jun 30, 2024 · ♥ 6 reactions · 5 comments · original Facebook post
Fasting & meal timingInsulin resistance & diabetesWeight, visceral & liver fat
AI summary & key facts

A Healthline report on a trial in recently diagnosed type 2 diabetes found 5:2 fasting with meal replacements produced more weight loss and larger HbA1c falls than metformin or empagliflozin over 16 weeks, plus improvements in waist, hips and blood pressure.

5:2 Intermittent Fasting produces more weight loss and better blood sugar control in diabetics than standard drugs (metformin or jardiance).

Quoted:

“Researchers found that people recently diagnosed with type 2 diabetes who did intermittent fasting using meal replacements lost more weight over 16 weeks compared to people who received standard diabetes medication.

Those who did intermittent fasting also saw greater improvements in their hemoglobin A1c (HbA1c or A1C) levels, a measure of blood glucose control.”

Quoted:

“People who did intermittent fasting lost an average of 21 pounds over 16 weeks, versus 12 to 13 pounds for those receiving one of the diabetes medications.

The intermittent fasting group also saw significant reductions in waist and hip circumference and systolic and diastolic blood pressure.

In addition, in the intermittent fasting group, HbA1c decreased by 1.9%, compared to a decrease of 1.6% in the metformin group and a decrease of 1.5% in the empagliflozin group.”

#fastingHD #diabetesHD #metforminHD #sglt2HD #jardianceHD

Research cited

Shared from Healthline · original post

A new study found that intermittent fasting could help people with type 2 diabetes lose weight and lower blood sugar levels.

← newer: Carnivore diet promotion rests on cherry-picked anecdotes wiolder: At least 7 g/day of olive oil linked to 28% lower dementia-r →